Esperion Therapeutics
ESPR
#6609
Rank
HK$6.42 B
Marketcap
HK$24.93
Share price
0.00%
Change (1 day)
176.18%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of March 2026 : HK$1.22 Billion

According to Esperion Therapeutics's latest financial reports the company has HK$1.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$1.30 B16.21%
2024-12-31HK$1.12 B74.96%
2023-12-31HK$0.64 B-50.73%
2022-12-31HK$1.30 B-35.53%
2021-12-31HK$2.02 B-14.46%
2020-12-31HK$2.36 B51.19%
2019-12-31HK$1.56 B46.8%
2018-12-31HK$1.06 B-31.9%
2017-12-31HK$1.56 B-4.67%
2016-12-31HK$1.64 B-0.27%
2015-12-31HK$1.64 B100.4%
2014-12-31HK$0.82 B76.27%
2013-12-31HK$0.46 B822.77%
2012-12-31HK$50.47 M313.62%
2011-12-31HK$12.2 M
2002-12-31HK$0.34 B-36.18%
2001-12-31HK$0.54 B0.06%
2000-12-31HK$0.54 B1094.17%
1999-12-31HK$45.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$102.50 B 8,272.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$68.62 B 5,505.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
HK$3.23 B 164.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
HK$1.33 B 9.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$2.30 B 87.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$17.42 B 1,323.20%๐Ÿ‡บ๐Ÿ‡ธ USA